MA26487A1 - PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Google Patents
PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.Info
- Publication number
- MA26487A1 MA26487A1 MA25047A MA25047A MA26487A1 MA 26487 A1 MA26487 A1 MA 26487A1 MA 25047 A MA25047 A MA 25047A MA 25047 A MA25047 A MA 25047A MA 26487 A1 MA26487 A1 MA 26487A1
- Authority
- MA
- Morocco
- Prior art keywords
- heterocyclecetohydrazides
- preparation
- pharmaceutical compositions
- compositions containing
- protease inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4506797P | 1997-04-29 | 1997-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26487A1 true MA26487A1 (en) | 2004-12-20 |
Family
ID=21935831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25047A MA26487A1 (en) | 1997-04-29 | 1998-04-24 | PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1019046A4 (en) |
| JP (1) | JP2002504097A (en) |
| KR (1) | KR20010020391A (en) |
| CN (1) | CN1261276A (en) |
| AR (1) | AR012622A1 (en) |
| AU (1) | AU7365198A (en) |
| BR (1) | BR9809333A (en) |
| CA (1) | CA2287989A1 (en) |
| CO (1) | CO4940477A1 (en) |
| HU (1) | HUP0001294A3 (en) |
| IL (1) | IL132629A0 (en) |
| MA (1) | MA26487A1 (en) |
| NO (1) | NO995268L (en) |
| PE (1) | PE69099A1 (en) |
| PL (1) | PL337725A1 (en) |
| TR (1) | TR199902703T2 (en) |
| WO (1) | WO1998048799A1 (en) |
| ZA (1) | ZA983522B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001526230A (en) | 1997-12-19 | 2001-12-18 | スミスクライン・ビーチャム・コーポレイション | Heteroaryl-substituted imidazole compounds, pharmaceutical compositions and uses thereof |
| US6100282A (en) * | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
| MA26618A1 (en) * | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA |
| US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| AU1909200A (en) | 1998-11-04 | 2000-05-22 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| CO5150165A1 (en) * | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | PROTEASE INHIBITORS: KATEPSIN K TYPE |
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| AU1588901A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
| JP2003513972A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
| JP2003513924A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
| US6797720B2 (en) | 1999-12-03 | 2004-09-28 | Ono Pharmaceutical Co., Ltd. | 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| KR20020062312A (en) * | 1999-12-03 | 2002-07-25 | 오노 야꾸힝 고교 가부시키가이샤 | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| SK13632002A3 (en) | 2000-03-21 | 2003-02-04 | Smithkline Beecham Corporation | C1-6-alkyl-4-amino-azepan-3-one compounds, process for the preparation thereof, pharmaceutical composition comprising the same and intermediates |
| WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| DE60227008D1 (en) * | 2002-07-04 | 2008-07-17 | Aventis Pharma Sa | NEW THIOPHENACYLHYDRAZINODERIVATES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT, PHARMACEUTICAL COMPOSITIONS AND NEW APPLICATIONS |
| KR100962972B1 (en) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| WO2011015524A2 (en) * | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
| WO2014031784A1 (en) * | 2012-08-23 | 2014-02-27 | Alios Biopharma, Inc. | Compounds for the treatment of paramoxyvirus viral infections |
| AU2014308991B2 (en) | 2013-08-21 | 2019-02-14 | Janssen Biopharma, Inc. | Antiviral compounds |
| MA41614A (en) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | ANTIVIRAL COMPOUNDS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK56798A3 (en) * | 1995-10-30 | 1998-12-02 | Smithkline Beecham Corp | Protease inhibitors, pharmaceutical composition containing them and their use |
-
1998
- 1998-04-24 MA MA25047A patent/MA26487A1/en unknown
- 1998-04-27 PE PE1998000320A patent/PE69099A1/en not_active Application Discontinuation
- 1998-04-28 ZA ZA983522A patent/ZA983522B/en unknown
- 1998-04-29 TR TR1999/02703T patent/TR199902703T2/en unknown
- 1998-04-29 HU HU0001294A patent/HUP0001294A3/en unknown
- 1998-04-29 CO CO98023491A patent/CO4940477A1/en unknown
- 1998-04-29 WO PCT/US1998/008740 patent/WO1998048799A1/en not_active Application Discontinuation
- 1998-04-29 AR ARP980101999A patent/AR012622A1/en unknown
- 1998-04-29 AU AU73651/98A patent/AU7365198A/en not_active Abandoned
- 1998-04-29 BR BR9809333-9A patent/BR9809333A/en not_active IP Right Cessation
- 1998-04-29 CA CA002287989A patent/CA2287989A1/en not_active Abandoned
- 1998-04-29 CN CN98806641A patent/CN1261276A/en active Pending
- 1998-04-29 JP JP54738998A patent/JP2002504097A/en active Pending
- 1998-04-29 KR KR1019997010013A patent/KR20010020391A/en not_active Application Discontinuation
- 1998-04-29 EP EP98920926A patent/EP1019046A4/en not_active Withdrawn
- 1998-04-29 IL IL13262998A patent/IL132629A0/en unknown
- 1998-04-29 PL PL98337725A patent/PL337725A1/en unknown
-
1999
- 1999-10-28 NO NO995268A patent/NO995268L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998048799A1 (en) | 1998-11-05 |
| IL132629A0 (en) | 2001-03-19 |
| CN1261276A (en) | 2000-07-26 |
| NO995268L (en) | 1999-11-15 |
| CA2287989A1 (en) | 1998-11-05 |
| TR199902703T2 (en) | 2000-02-21 |
| PE69099A1 (en) | 1999-09-26 |
| AR012622A1 (en) | 2000-11-08 |
| PL337725A1 (en) | 2000-08-28 |
| CO4940477A1 (en) | 2000-07-24 |
| HUP0001294A2 (en) | 2001-04-28 |
| EP1019046A4 (en) | 2002-11-27 |
| AU7365198A (en) | 1998-11-24 |
| EP1019046A1 (en) | 2000-07-19 |
| ZA983522B (en) | 1998-10-29 |
| HUP0001294A3 (en) | 2001-06-28 |
| BR9809333A (en) | 2000-07-04 |
| JP2002504097A (en) | 2002-02-05 |
| KR20010020391A (en) | 2001-03-15 |
| NO995268D0 (en) | 1999-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26494A1 (en) | NOVEL PROTEASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26487A1 (en) | PROTEASE INHIBITOR HETEROCYCLECETOHYDRAZIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26451A1 (en) | APO B / MTP SECRETION INHIBITOR AMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| FR2748026B1 (en) | NOVEL METALLOPROTEASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FR2780057B1 (en) | PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA24529A1 (en) | NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. | |
| MA26472A1 (en) | N-HYDROXY-B-SULFONYLPROPIONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26499A1 (en) | TETRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26743A1 (en) | NEW METALLOPROTEASE INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26508A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE, AND PROCESS FOR THEIR PREPARATION. | |
| MA26630A1 (en) | NOVEL 4-PHENYLPYPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26622A1 (en) | NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26424A1 (en) | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26468A1 (en) | SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26432A1 (en) | DERIVATIVES OF 2- (2-OXO-ETHYLIDENE) -IMIDAZOLIDINE-4-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26654A1 (en) | NEW PYRROLOPYRIMIDINES PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26559A1 (en) | D-PROLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | |
| MA26516A1 (en) | TARTRATE OF A SUBSTITUTED DIPEPTIDE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | |
| DZ2890A1 (en) | 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them. | |
| MA26558A1 (en) | NOVEL 6-0-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26433A1 (en) | PYRIDYLPYRROLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA26490A1 (en) | NOVEL TETRAHYDROISOQUINOLEIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26514A1 (en) | PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26492A1 (en) | NOVEL PROTEASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26519A1 (en) | AZETIDINYLPROPYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |